<p><h1>Drug-Eluting Balloons Market Research Report Reveals The Latest Trends And Opportunities of this Market for Period from 2024 - 2031</h1></p><p><strong>Drug-Eluting Balloons Market Analysis and Latest Trends</strong></p>
<p><p>Drug-Eluting Balloons are medical devices used in the treatment of narrowed arteries by delivering drugs directly to the site of the blockage. The drugs help to prevent the re-narrowing of the arteries, known as restenosis, after the balloon angioplasty procedure. These balloons are coated with a special medication that gets released during the inflation of the balloon and is absorbed by the surrounding tissue.</p><p>The Drug-Eluting Balloons Market is expected to grow at a CAGR of 14.5% during the forecast period. The key factors driving the growth of the market include the increasing prevalence of cardiovascular diseases, rising geriatric population, and advancements in minimally invasive procedures. Additionally, the growing demand for cost-effective treatment options and the development of innovative drug delivery technologies are also contributing to the market growth.</p><p>Some of the latest trends in the Drug-Eluting Balloons Market include the development of bioabsorbable drug-eluting balloons, which minimize the risk of long-term complications, and the increasing adoption of drug-coated balloons in peripheral vascular interventions. Moreover, the growing focus on research and development activities to enhance the efficacy and safety of drug-eluting balloons is expected to drive further market growth in the coming years.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp;</strong> <a href="https://www.reliableresearchreports.com/enquiry/request-sample/1695092">https://www.reliableresearchreports.com/enquiry/request-sample/1695092</a></p>
<p>&nbsp;</p>
<p><strong>Drug-Eluting Balloons Major Market Players</strong></p>
<p><p>The Drug-Eluting Balloons Market is highly competitive with key players such as Boston Scientific, Medtronic, Cook Medical, C.R. Bard, B. Braun, Eurocor GmbH, Blue Medical, Bayer, Aachen Resonance, and Acrostak leading the market. Boston Scientific, a prominent player in the market, offers drug-eluting balloons designed to treat coronary artery disease. In recent years, Boston Scientific has seen significant market growth due to its innovative products and strategic partnerships with healthcare providers.</p><p>Medtronic is another major player in the Drug-Eluting Balloons Market, with a focus on developing advanced medical devices for the treatment of cardiovascular diseases. The company has witnessed robust market growth and is expected to continue expanding its market share in the coming years. Cook Medical is also a key player in the market, known for its high-quality drug-eluting balloons used in the treatment of peripheral artery disease.</p><p>C.R. Bard, a subsidiary of BD (Becton, Dickinson and Company), offers a wide range of drug-eluting balloons for various medical applications. The company has experienced steady market growth and is projected to maintain its strong position in the market. B. Braun, a leading provider of medical devices and healthcare solutions, has also made significant strides in the Drug-Eluting Balloons Market with its innovative products.</p><p>The market size of the Drug-Eluting Balloons Market is expected to grow steadily in the coming years, driven by increasing prevalence of cardiovascular diseases and rising demand for minimally invasive treatment options. The sales revenue of key players such as Boston Scientific, Medtronic, and Cook Medical is estimated to be in the range of millions to billions of dollars, reflecting the significant market potential of the Drug-Eluting Balloons Market.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For Drug-Eluting Balloons Manufacturers?</strong></p>
<p><p>The global Drug-Eluting Balloons market is experiencing significant growth due to their ability to effectively deliver drugs directly to the site of treatment, reducing the risk of restenosis. Key factors driving market growth include increasing prevalence of cardiovascular diseases, growing demand for minimally invasive procedures, and advancements in technology. The market is projected to continue its upward trajectory, with expanding applications in peripheral artery disease and coronary artery disease. Key players are focusing on product innovation and strategic partnerships to capitalize on these growth opportunities. The future outlook for the Drug-Eluting Balloons market remains positive, with sustained growth expected in the coming years.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report:</strong> <a href="https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1695092">https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1695092</a></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The Drug-Eluting Balloons Market Analysis by types is segmented into:</strong></p>
<p><ul><li>Coronary Drug Eluting Balloon</li><li>Peripheral Drug Eluting Balloon</li><li>Others</li></ul></p>
<p><p>Drug-eluting balloons are medical devices used in the treatment of coronary and peripheral artery diseases. The market is segmented into coronary drug-eluting balloons, which are used in the treatment of coronary artery disease, and peripheral drug-eluting balloons, which are used in the treatment of peripheral artery diseases. Other types of drug-eluting balloons are also available for specific applications. These devices deliver medication directly to the affected area, reducing the risk of restenosis and improving patient outcomes.</p></p>
<p><strong>Purchase this Report:&nbsp;</strong><a href="https://www.reliableresearchreports.com/purchase/1695092">https://www.reliableresearchreports.com/purchase/1695092</a></p>
<p>&nbsp;</p>
<p><strong>The Drug-Eluting Balloons Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>Hospitals and Ambulatory Surgery Centers</li><li>CATH Labs</li><li>Others</li></ul></p>
<p><p>Drug-eluting balloons are widely used in hospitals, ambulatory surgery centers, and cath labs for various medical procedures such as angioplasty and stenting. These devices release drugs directly to the treatment site, reducing the risk of restenosis and improving patient outcomes. Additionally, drug-eluting balloons are also used in other medical facilities and settings for the treatment of vascular diseases. Their versatility and effectiveness make them a valuable tool in the field of interventional cardiology and vascular surgery.</p></p>
<p>&nbsp;</p>
<p><strong>In terms of Region, the Drug-Eluting Balloons Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The Drug-Eluting Balloons market is expected to witness significant growth in the regions of North America (NA), Asia Pacific (APAC), Europe, United States of America (USA) and China. Among these regions, North America and Europe are anticipated to dominate the market with a market share of 30% and 25% respectively. Asia Pacific and China are also projected to experience substantial growth, capturing market shares of 20% and 15% respectively.</p></p>
<p><strong>Purchase this Report: </strong><a href="https://www.reliableresearchreports.com/purchase/1695092">https://www.reliableresearchreports.com/purchase/1695092</a></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;</strong><a href="https://www.reliableresearchreports.com/enquiry/request-sample/1695092">https://www.reliableresearchreports.com/enquiry/request-sample/1695092</a></p>
<p><strong></strong></p>
<p>Check more reports on https://www.reliableresearchreports.com/</p>